Posted by Jason Smith at 10:50AM on October 12th
Pharmaceutical giant Pfizer (PFE) sent King Pharmaceuticals (KG) soaring on Tuesday after agreeing to buy the firm for $3.6 billion or $14.25 per share in cash, a 40% premium to King’s closing value on Monday. The acquisition will expand Pfizer’s exposure to…
Select Healthcare Stocks Float Higher Amid Broad Sell-Off (OSIR, NBS, CUR, KOOL, GERN, CPIX, OMER, DRRX, MIPI, MNKD)
Posted by Jason Smith at 2:58PM on June 24th
Various segments of the healthcare industry staged a low-volume rally on Thursday as the major market benchmarks traded in the red.
As a whole, the Stem Cell Stocks Index is ahead by 3% for the session as Osiris Therapeutics (OSIR) and Neostem (NBS) soar…
|Home | Find | Research | Track | Register | My Account | Logout||Web site design by LightMix|
|© 2007-2013 Indie research Corp. All rights reserved.|